D – Delphi’s
Rooted in Delphi’s legacy of excellence in pharma strategy and field force optimization. We bring decades of proven experience in developing HCP segmentation and targeting frameworks that translate into commercial success.
I – Intelligent
Informed by proprietary data synthesis and behavioral modeling.
Our intelligent approach integrates multiple data sources, from prescribing patterns to market signals, to decode what drives HCP decision-making.
A – AI/Algorithm-Augmented
Enhanced by artificial intelligence and Delphi’s custom-built algorithms.
This layer delivers predictive targeting that dynamically identifies and prioritizes high-value HCPs with the greatest NbRX potential.
N – NbRX Growth
Laser-focused on new-to-brand prescription acceleration.
DIANA goes beyond volume metrics, honing in on initiators who are ready to prescribe—increasing share-of-voice and market adoption.
A – Approach
A scalable, field-deployable strategy that turns insight into action.
From segmentation to messaging and call planning, DIANA ensures that every tactical move is evidence-based and outcome-oriented.
1. C-Suite / Executive Leadership
2. Global / Market Access
3. Brand Leadership
4. Medical Affairs
5. Field Leadership
6. Sales Reps
7. Commercial-Medical Collaboration
8. HCPs & Patients